We are live on ! Find out more
SER icon

Serina Therapeutics
SER

Fund managers haven’t disclosed any holdings of SER yet.

SER Hedge Fund Activity: Q1 2026 in Review

25 of the 8,130 institutional investors tracked by Wall St. Rank reported a position in Serina Therapeutics (SER) for Q1 2026, worth a combined $2.86M — up 248% from $822K a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new SER positions and 5 closed out — a net gain of 5 holders — while 6 added to existing stakes and 1 trimmed.

The largest buyer was Sio Capital Management, opening a new position worth an estimated $2.2M. The largest seller was Broadwood Capital, exiting entirely with an estimated $104K sold.

  • 25 institutional investors held Serina Therapeutics (SER) as of Q1 2026, up from 22 in Q4 2025.
  • Funds reported $2.86M of Serina Therapeutics stock for Q1 2026, up 248% quarter-over-quarter.
  • 10 funds opened new Serina Therapeutics positions in Q1 2026 and 5 closed out, a net change of +5 holders.
  • The largest Serina Therapeutics buyer in Q1 2026 was Sio Capital Management, an estimated $2.2M added.
  • The largest Serina Therapeutics seller in Q1 2026 was Broadwood Capital, an estimated $104K sold.

Based on aggregated 13F filings for Q1 2026.